Incidental adrenal pheochromocytoma. Report on 5 operated patients and update of the literature

Archivio Italiano di Urologia e Andrologia

Volumn 75, Issue 4, 2003, Pages 217-225

  Porcaro, Antonio Benito ^a,b   Novella, Giovanni ^a   Ficarra, Vincenzo ^a   D'Amico, Antonio ^a   Antoniolli, Stefano Zecchini ^a   Curti, Pierpaolo ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b OSPEDALE POLICLINICO   (Italy)

Author keywords

Adrenal incidentaloma; Pheochromocytoma

Indexed keywords

LABETALOL; NITROPRUSSIDE SODIUM;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ARTICLE; AUTOTRANSPLANTATION; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LAPAROSCOPIC SURGERY; MALE; MORBIDITY; MORTALITY; PHEOCHROMOCYTOMA; PREOPERATIVE CARE; QUALITY OF LIFE; SURVIVAL RATE; TUMOR VOLUME; URINARY EXCRETION;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ADRENALECTOMY; AGED; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; PREOPERATIVE CARE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1642512505     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (163)

1. Barzon L, Boscaro M. Diagnosis and management of adrenal incidentalomas. J Urol 2000; 163:398
2. Murai M, Baba S, Nakashima J, Tachibana M. Management of incidentally discovered adrenal masses. World J Urol 1999; 17:9
3. Mantero E, Arnaldi G. Management approaches to adrenal incidentalomas. A view from Ancona, Italy. Endocrinol Metab Clin North Am 2000; 29:107
4. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000; 85:634
5. Proye C, Jafari Manjili M, Combemale F et al. Experince gained from operation of 103 adrenal incidentalomas. Langenbecks Arch Surg 1998; 383:330
6. Walther MM, Keiser HR, Linehan WM. Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol 1999; 17:35
7. Mannelli M, Ianni L, Cilotti A, Conti A. Pheochromocytoma in Italy: a multicentric retrospective study. Eur J Endocrinol 1999; 141:619
8. Luton JP, Martinez M, Coste J, Bertherat J. Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center. Eur J Endocrinol 2000; 143:111
9. Klingler PJ, Fox TP, Menke DM, Knudsen JM, Fulmer JT. Pheochromocytoma in an incidentally discovered asymptomatic cystic adrenal mass. Mayo Clin Proc 2000; 75:517
10. Troncone L, Ruffini V. Nuclear medicine therapy of pheochromocytoma and paraganglioma. Q J Nucl Med 1999; 43:344
11. Noshiro T, Shimuzu K, Watanabe T, et al. Changes in clinical features and long-term prognosis in patients with pheochromocytoma. Am J Hypertens 2000; 13:35
12. Sisson JC, Shapiro B, Shulkin BL, Urba S, Zempel S, Spaulding S. Treatment of malignant pheochromocytomas with 131-I-metaiodobenzylguanidine and chemotherapy. Am J Clin Oncol 1999; 364
13. Iwabuchi M, Oki Y, Nakamura H. Palliative chemotherapy for malignant pheochromocytoma: symtomatic palliation of two cases. Intern Med 1999; 38:433
14. Takahashi K, Ashizawa N, Minami T, et al. Malignant pheochromocytoma with multiple hepatic metastases treated by chemotherapy and transcatheter arterial embolization. Intern Med 1999; 38:349
15. Boneschi M, Erba M, Rinaldi P, Cusmai F, Miani S. Malignant pheochromocytoma. A case report and comments on a rare pathology. Minerva Chir 1999; 54:73
16. Delplace C, Bourlier P, Babuty D et al. Right adrenal recurrence of pheochromocytoma discovered 24 years after ablation of ectopic pheocochromocytomas. Arch Mal Coeur Vaiss 1999; 92:363
17. John H, Ziegler WH, Hauri D, Jaeger P. Pheochromocytomas: can malignant potentials be predicted? Urology 1999; 53:679
18. Tada K, Okuda Y, Yamashita K. Three cases of malignant pheochromocytoma with multiple metastases treated with cyclophosphamide, vincristine and decarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercathecholaminemia. Horm Res 1998; 49:295
19. Gill PS. Acute heart failure in the parturient: do not forget phaeochromocytoma. Anaesth Intensive Care 2000; 28:322
20. Almog B, Kupfermine MJ, Many A, Lessing JB. Pheochromocytoma in pregnancy: a case report and review of the literature. Acta Obstet Gynecol Scand 2000; 79:709
21. Kuvacic I, Kalafatic D, Skrablin S, et al. Pheochromocytoma with negative urinalysis in pregnancy. Croat Med J 2000; 41:96
22. Huddle KR, Nagar A. Phaeochromocytoma in pregnancy. Aust N Z J Obstet Gynaecol 1999; 39:203
23. Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK. Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynecol Surv 1999; 54:728
24. Finkenstedt G, Gasser RW, Hofle G, et al. Pheochromocytoma and sub-clinical Cushing's syndrome during pregnancy: diagnosis, medical pretreatment and cure by laparoscopic unilateral adrenalectomy. J Endocrinol Invest 1999; 22:551
25. Hermayer KL, Szpiech M. Diagnosis and management of pheochromocytoma during pregnancy: a case report. Am J Med Sci 1999; 318:186
26. Zangrillo A, Valentini G, Casati A, Torri G. Myocardial infarction and death after caesarean section in a woman with protein S deficiency and undiagnosed phaechromocytoma. Eur J Anaesthesiol 1999; 16:268
27. Harrington JL, Farley DR, van Heerden JA, Ramin KD. Adrenal tumors and pregnancy. World J Surg 1999; 23:182
28. Smith CM, Wigent PJ. Pheochromocytoma in pregnancy: considerations for the advanced practice nurse. J Perinat Neonatal Nurs 1998; 12:11
29. Castaigne V, Afriat R, Cambouris Perrine S, Radu S, Desdouit J, Freund M. Pheochromocytoma associated with pregnancy. Report of 2 cases and review of the literature. J Gynecol Obstet Biol Reprod 1998; 27:622
30. Demeure MI, Carlsen B, Traul D et al. Laparoscopic removal of a right adrenal pheochromocytoma in a pregnant woman. J Laparoendosc Adv Surg Tech A 1998; 8:315
31. Ross JH. Pheochromocytoma. Special considerations in children. Urol Clin North Am 2000; 27:393
32. Laporte R, Godart F, Breviere GM, Vaksmann G, Francart C, Rey C. Severe arterial hypertension and pheochromocytoma in childhood. Case report and review of the literature. Arch Mal Coeur Vaiss 2000; 93:627
33. Le Hir H, Colucci D'Amato LG, Charlet Berguerand N, et al. High levels of tyrosin phosphorylated proto-ret in sporadic pheochromocytomas. Cancer Res 2000; 60:1365
34. de Graaf JS, Lips CJ, Rutter JE, van Vroonhoven TJ. Subtotal adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2A. Eur J Surg 1999; 165:535
35. Proye CA, Nguyen HH. Current perspectives in the surgery of multiple endocrine neoplasias. Aust N Z J Surg 1999; 69:106
36. Akama H, Noshiro T, Kimura N et al. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene. Intern Med 1999; 38:145
37. Smith Hicks CL, Sizer KC, Powers JF, Tischler AS, Costantini F. C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B. Embo J 2000; 19:612
38. Correia MJ, Lopes LO, Bugalho MJ, et al. Multiple endocrine neoplasia type 2A. Study of a family. Rev Port Cardiol 2000; 19:11
39. Mossner R, Keidel M. Malignant pheochromocytoma with progressive paraparesis in von Hippel-Lindau disease. Eur J Neurol 2000; 7:439
40. Kashyap AS, Kashyap S. Phaeochromocytoma in VHL disease. Postgrad Med J 2000; 76:190
41. Duerr EM, Gim O, Neuberg DS et al. Differences in allelic distribution of two polymorphisms in the VHL-associated gene CUL 2 in pheochromocytoma patients without somatic CUL 2 mutations. J Clin Endocrinol Metab 1999; 84:3207
42. Walther MM, Reiter R, Keiser HR, et al. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 1999; 162:659
43. Ferragut J, Caimari M, Rituerto B, Gomez Rivas B, Herrera M, Alonso F. Pheochromocytoma and clear-cell renal carcinoma in a child with von Hippel-Lindau disease: a patient report. J Pediatr Metab 1999;579
44. Hes FG, Feldberg MA. Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses). Eur Radiol 1999; 9:598
45. Walther MM, Keiser HR, Choyke PL, Rayford W, Lyne JC, Linehan VM. Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. J Urol 1999; 161:395
46. McCann J. Tracking von Hippel-Lindau mutations for patterns of disease. J Natl Cancer Inst 1999; 91:12
47. Quarles Van Ufford Manesse P, Castro Cabezas M, Vroom TM, Van Gils A, Lips CJ, Niermeijer P. A patient with neurofibromatosis type 1 and watery diarrhoea syndrome due to a VIP producing adrenal pheochromocytoma. J Internal Med 1999; 246:231
48. Lam J, Henriquez R, Cruzat C. Pheochromocytoma and von Recklinghausen neurofibromatosis: postpartum crisis and renal artery thrombosis. Rev Med Chil 1998; 126:1367
49. Bethea L, Khan S. Behcet's disease and pheochromocytoma. J S C Med Assoc 1999; 95:295
50. Kimura T, Ikemoto I, Furuta N, Ohishi Y. A case of Sipple syndrome whose bilateral pheochromocytomas were resected separately after a 3 year interval. Hinyokitta Kiyo 2000; 46:251
51. Gill IS, Meraney AM, Bravo EL, Novick AC. Pheochromocytoma coexisting with renal artery lesions. J Urol 2000; 164:296
52. Alamowitch B, Mausset V, Ruiz A, et al. Non-secreting pheochromocytoma of the broad ligament revealed by appendicular peritonitis. Presse Med 1999; 28:225
53. Lumachi F, Polistina F, Favia G, D'Amico DF. Extraadrenal and multiple pheochromocytomas. Are there any really differences in pathophysiology and outcome? J Exp Clin Cancer Res 1998; 17:303
54. Tischler AS. Divergent differentiation in neuroendocrine tumors of the adrenal gland. Semin Diagn Pathol 2000; 17:120
55. Mihai R, Wong NA, Luckett M, Sheffield E, Farndon JR. No correlation between phaechromocytoma catecholamine secretion and granule ultrastructure. Br J Surg 1998; 85:1681
56. Moreno AM, Castilla Guerra L, Martinez Torres MC et al. Expression of neuropeptides and other neuroendocrine markers in human phaeochromocytomas. Neuropeptides 1999; 33:159
57. Yanaihara H, Hata M, Nishikawa Y, Hoshino M, Yanaihara N, Murai M. Application of region-specific immunoassay for human chromogranin A: substantial clue for detection and measurement of chromogranin A in human plasma. Regul Pept 1999; 80:83
58. Van der Harst E, Bruining HA, Jaap Bonjer H, et al. Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases? J Pathol. 2000; 191:175
59. Fogt F, Zimmerman RL, Mulligan N, et al. BCL-2 expression and inhibin-A in adrenal neoplasms: a comparative study. Int J Mol Med 1999; 3:271
60. Yang T, Martignetti JA, Massa SM, Longo FM. Leukocyte common-antigen related tyrosine phosphatase receptor: altered expression of mRNA and protein in the New England Deaconess Hospital rat line exhibiting spontaneous pheochromocytoma. Carcinogenesis 2000; 21:125
61. Edstrom E, Mahlamaki E, Nord B et al. Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3 q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology. Am J Pathol 2000; 156:651
62. Bamberger CM, Else T, Bamberger AM, Frilling A, et al. Telomerase activity in benign and malignant adrenal tumors. Exp Clin Endocrinol Diabetes 1999; 107:272
63. Maryniak RK, Szczaluba K, Ignatowska Switalska M, Wocial B, Januszewicz W. Immunomorphological studies and cytometric DNA ploidy in diagnostics of pheochromocytoma. Pol J Pathol 2000; 51:83
64. Le Hir H, Charlet Berguerand N, Gimenez Roqueplo A et al. Relative expression of the RET9 and RET51 isoforms in human pheochromocytomas. Oncology 2000; 58:311
65. Pfragner R, Behmel A, Smith DP, et al. First continuous human pheochromocytoma cell line: KNA. Biological, cytogenetic and molecular characterization of KNA cells. J Neurocytol 1998; 27:175
66. Nilsson O, Tisell LE, Jansson S, Ahlman H, Gimm O, Eng C. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET ∀804L mutation. JAMA 1999, 281:1587
67. Yoshimoto T, Naruse M, Zeng Z, et al. The relatively high frequency of p53 gene mutations in multiple and malignant pheochromocytomas. J Endocrinol 1998; 159:247
68. De Krijer RR, van der Harst E, van der Ham F et al. Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in pheochromocytomas. J Pathol 1999; 188:51
69. Lee SD, Lee BD, Han JM, Kim JH, Kim Y, Suh PG, Ryu SH. Phospholipase D2 activity suppresses hydrogen peroxide-induced apoptosis in PC12 cells. J Neurochem 2000; 75:1053
70. Nanmoku T, Isobe K, Sakurai T et al. Orexins suppress catecholamine synthesis and secretion in cultured PC12 cells. Biochem Biophys Res Commun 2000; 274:310
71. Ilvesmaki V, Liu J, Heikkila P, Kahri AI, Voutilainen R. Expression of insulin-like growth factor binding protein 1-6 genes in adrenocortical tumors and pheochromocytomas. Horm Metab Res 1998;30:619
72. Reubi JC, Laderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res 2000; 60:3105
73. Liu J, Heikkila P, Kahri AI, Voutilainen R. Expression of activin A and its receptors in human pheochromocytomas. J Endocrinol 2000; 165:503
74. Grazzini E, Breton C, Derick S, et al. Vasoppressin receptors in human adrenal medulla and pheochromocytoma. J Clin Endocrinol Metab 1999; 84:2195
75. Isobe K, Nakai T, Yashiro T, et al. Enhanced expression of mRNA coding for the adrenaline-synthesizing enzyme phenylethanolamine-N-methyl transferase in adrenaline-secreting pheochromocytomas. J Urol 2000; 163:357
76. Sajuan Portugal FJ, Baila Sancho E, Faure Grima A. Adrenalin-secreting pheochromocytoma. Rev Clin Exp 1999; 199:115
77. Bartolacci M, Bartolacci S, Leombruni E, Annunziata A, Di Rienzo M, Picardi N. Adrenal incidentaloma: a dopamine-secreting pheochromocytoma with an atypical clinical picture. A case report and review of the literature. Ann Ital Chir 1998; 69:805
78. Minamiguchi N, Inui E, Nukui M. A case of dopamine-secreting pheochromocytoma. Hinyokika Kiyo 1999; 45:831
79. Beltowski J. Adrenomedullin. Postepy Hig Med Dosw 1999; 53:99
80. Liu J, Kahri AI, Heikkila P, Voutilainen R. Regulation of neuropetide Y mRNA expression in cultured human pheochromocytoma cells. Eur J Endocrinol 1999; 141:431
81. Eurin J, Barthelemy C, Masson F, et al. Release of neuropeptide Y and hemodynamic changes during surgical removal of human pheochromocytomas. Regul Pept 2000; 86:95
82. Van Eeckhout P, Shungu H, Descamps FX, et al. Acute watery diarrhea as the initial presenting feature of a pheochromocytoma in a 84 year old female patient. Horm Res 1999; 52:101
83. Komiyama Y, Nishimura N, Munahata M, et al. Increases in plasma ouabainlike immunoreactivity during surgical extirpation of pheochromocytoma. Hypertens Res 1999; 22:135
84. Golbasi Z, Sakalli M, Ciceh D, Aydogdu S. Dynamic left ventricular outflow tract obstruction in a patient with pheochromocytoma. Jpn Heart J 1999; 40:831
85. Moulin C, Delomez M, Bauchart JJ, Lesenne M, Asseman P, Thery C. Pheochromocytoma simulating myocardial infarct. Apropos of a case. Arch Mal Coeur Vaiss 1999; 92:1789
86. Brilakis ES, Young WF Jr, Wilson JW, Thompson GB, Munger TM. Reversible catecholamine-induced cardiomyopathy in a heart transplant candidate without persitent or paroxysmal hypertension. J Heart Lung Transplant 1999; 18:376
87. Col V, de Canniere L, Messaoudi L, Michel L, Donckier J. Heart failure induced by pheochromocytoma: laparoscopic treatment and intraoperative changes of several new cardiovascular hormones. Horm Res 1999; 51:50
88. Gatzoulis KA, Tolis G, Theopistou A, Gialafos JH, Toutouzas PK. Cardiomyopathy due to a pheochromocytoma. A reversible entity. Acta Cardiol 1998; 53:227
89. Yoshinaga K, Torii H, Tahara M. A serial echocardiographic observation of acute heart injury associated with pheochromocytoma crisis. Int J Cardiol 1998; 66:199
90. De Backer TL, De Buyzere ML, Taeymans Y, Kunnen P, Rubens R, Clement DL. Cardiac involvement in pheochromocytoma. J Hum Hypertens 2000; 14:469
91. Casazza F, Capozi A, Conconi B, Schiaffino E. Acute myocardial damage from a pheochromocytoma. Ital Heart J 2000; 1:686
92. Hanna NN, Kenady DE. Hypertension in patients with pheochromocytoma. Curr Hypertens Rep. 1999; 1:540
93. May EE, Beal AL, Beilman GJ. Traumatic hemorrhage of occult pheochromocytoma: a case report and review of the literature. Am Surg, 2000; 66:720
94. Bonati L, Rubini P, Guareschi C. Diagnosis and treatment of pheochromocytoma. Minerva Chir 2000; 55:333
95. Witteles RM, Kaplan EL, Roizen MF. Sensitivity of diagnostic and tests for pheochromocytoma in clinical practice. Arch Intern Med. 2000; 160:2521
96. Ito Y, Obara T, Okamoto T, et al. Efficacy of single-voided urine metanephrine and normetanephrine assay for diagnosing pheochromocytoma. World J Surg 1998; 22:684
97. Little AF. Adrenal gland and renal sonography. World J Surg 2000; 24:82
98. Shkrob OS, Dadvani SA, Kuzin NM, et al. Intraoperative ultrasonography in surgery on organs of abdominal cavity and retroperitoneal space. Khirurgiia Mosk 2000; 2:28
99. Brunt LM, Bennett HF, Teefey SA, Moley JF, Middleton WD. Laparoscopic ultrasound imaging of adrenal tumors during laparoscopic adrenalectomy. Am J Surg 1999; 178:490
100. Walther MM, Herring J, Choyke PL, Linehan WM. Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. J Urol. 2000; 164:14
101. Sosa JA, Udelsman R. Imaging of the adrenal gland. Surg Oncol N Am 1999; 8:109
102. Lau H, Lo CY, Lam KY. Surgical implications of underestimation of adrenal tumor size by computed tomography. Br J Surg 1999; 86:385
103. Tachibana M. Management of incidentally discovered adrenal masses. World J Urol 1999; 17:9
104. Heinz Peer G, Honigschnabl S, Schneider B, Kaserer K, Lechner G. Characterization of adrenal masses using MR imaging with histopathologic correlation. AJR 1999; 173:15
105. Fujita A, Hyodoh H, Kawamura Y, Kanegae K, Furuse M, Kanazawa K. Use of fusion images of 1-131 metaiodobenzylguanidine, SPECT, and magnetic resonance studies to identify a malignant pheochromocytoma. Clin Nucl Med 2000; 25:440
106. Owens J, Bolster AA, Prosser JE, et al. No-carrier-added 1231-MIBG: an initial clinical study in patients with phaeochromocytoma. Nucl Med Commun 2000; 21:437
107. De Graaf JS, Dullaart RP, Kok T, Piers DA, Zwierstra RP. Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II. Eur J Surg 2000; 166:289
108. Komori T, Narabayashi I, Doi K, Sueyoshi K, Tatsu Y, Utsunomiya K. A case of local recurrent pheochromocytoma: usefulness of 1-123 MIBG early SPECT and maximum intensity projection images. Clin Nucl Med 2000; 25:285
109. Tormey WP, Keeling F, Lee MJ. 1231-metaiodobenzylguanidine scans in phaeochromocytoma diagnosis: current clinical practice and relationship to biochemical screening. Int J Clin Pract 1999; 53:428
110. Boersma HH, Wensing JW, Kho TL, de Brauw LM, Liem IH, van Kroonenburgh MJ. Transient enhanced uptake of 1231-metaiodobenzylguanidine in the contralateral adrenal region after resection of an adrenal pheochromocytoma. N Engl J Med. 2000; 342:1450
111. Takahashi N, Suzuki T, Yamaya K, Funyu T. The usefulness of [1311]-metaiodobenzylguanidine ([1311]-MIBG) scintigraphy performed one week after administration in diagnosing pheochromocytoma. Int J Urol. 1999; 6:331
112. Furuta N, Kiyota H, Yoshigoe F, Hasegawa N, Ohishi Y. Diagnosis of pheochromocytoma using 123-I- compared with 131-I-metaiodobenzylguanidine scintigraphy. Int J Urol 1999; 6:119
113. Nguyen HH, Proye CA, Carnaille B, Combemale F, Pattou FN, Huglo D. Tumor size: the only predictive factor for 1311 MIBG uptake in pheochromocytoma and paraganglioma. Aust N Z J Surg 1999; 69:350
114. Letizia C, De Toma G, Massa R, Corsi A, Caliumi C, Subioli S, D'Erasmo E. False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan. J Endocrinol Invest 1998; 21:779
115. Suga K, Ogasawara N, Ariga M, et al. Alteration of myocardial metaiodobenzylguanidine uptake after treatment of phaeochromocytoma and neuroblastoma. Eur J Nucl Med. 2000; 27:574
116. Bergstrom M, Juhlin C, Bonasera TA, et al. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate. J Nucl Med 2000; 41:275
117. Maurea S, Mainolfi C, Bazzicalupo L, et al. Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. Am J Roentgenol 1999; 173:25
118. Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-(fluorine-18) fluoro-2-deoxy-D-glucose PET. Radiology 1999; 212:35
119. Mateos Fernandez J, Pons Pons F, Fuster Pelfort D, et al. 111In-pentetreotide in the study of tumors expressing somatostatin receptors. Rev Esp Med Nucl 1999; 18:325
120. Kennedy JW, Dluhy RG. The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management. Yale J Biol Med 1997, 70:565
121. Shidam VB, Galindo LM. Pheochromocytoma. Cytologic findings on intraoperative scrape smears in five cases. Acta Cytol 1999; 43:207
122. Kievit J, Haak H. Diagnosis and treatment of adrenal incidentaloma: a cost effectiveness analysis. Endocrinol Metab Clinic North Am 2000; 29:69
123. Casazza F, Capozi A, Conconi B, Schiaffino E. Acute myocardial damage from a pheochromocytoma. Ital Heart J 2000; 1:686
124. Hack HA. The perioperative management of children with phaeochromocytoma. Paediatr Anaesth 2000; 10:463
125. Joris JL, Hamoir EE, Hartstein GM, et al. Hemodynamic release during laparoscopic adrenalectomy for pheochromocytoma. Anesth Analg 1999; 88:16
126. Inabnet WB, Pitre J, Bernard D, Chapuis Y. Comparison of the hemodynamic parameters of open and laparoscopic adrenalectomy for pheochromocytoma. World J Surg 2000; 24:574
127. De La Chapelle A, Deghmani M, Dureuil B. Peritoneal insufflation can be a critical moment in the laparoscopic surgery of pheochromocytoma. Ann Fr Anesth Reanim 1998; 17:1184
128. Porcaro AB, Cavalleri S, Ballista C, et al. Modern imaging methods and preoperative management of pheochromocytoma: review of the literature and case report. Arch Esp Urol 2000; 53:749
129. Prys Roberts C. Phaeochromocytoma: recent progress in its management. Br J Anaesth 2001; 85:44
130. Lertakyamanee N, Lertakyamanee J, Somprakit P, et al. Surgery and anesthesia for pheochromocytoma: a series of 40 operations. J Med Assoc Thai 2000; 83:921
131. Witteles RM, Kaplan EL, Roizen MF. Safe and cost-effective preoperative preparation of patients with pheochromocytoma. Anesth Analg 2000; 91:302
132. Chiu M, Crosby ET, Yelle JD. Anesthesia for laparoscopic adrenalectomy (pheochromocytoma) in an anemic adult Jehovah's Witness. Can J Anaesth 2000; 47:566
133. Koriyama N, Kakei M, Yaekura K, et al. Control of catecholamine release and blood pressure with octreotide in a patient with pheochromocytoma: a case report with in vitro studies. Horm Res 2000; 53:46
134. Pitt Miller P, Primus E. Use of magnesium sulphatc as adjunctive therapy for resection of phaeochromocytoma. West Indian Med J 2000; 49:73
135. Colson P, Ryckwaert F, Ribstein J, Mann C, Dareau S. Haemodynamic heterogeneity and treatment with the calcium channel blocker nicardipine during phaechromocytoma surgery. Acta Anacsthesiol Scand 1998; 42:1114
136. Sprung J, O'Hara JF Jr, Gilla IS, Abdelmalak B, Sarnaik A, Bravo EL. Anesthetic aspects of laparoscopic and open adrenalectomy for pheochromocytoma. Urology 2000; 55:339
137. Joris JL, Hamoir EE, Hartstein GM, et al. Hemodynamic changes and catecholamine release during laparoscopic adrenalectomy for pheochromocytoma. Anesth Analg 1999; 88:16
138. Subramaniam R, Pandit B, Sadhasivam S, Sridevi KB, Kaul HL. Retroperitoneoscopic excision of pheochromocytoma: hemodynamic events, complications, and outcome. Anaesth Intensive Care 2000; 28:49
139. Shupak RC. Difficult anesthetic management during pheochromocytoma surgery. J Clin Anesth 1999; 11:247
140. Rii A, Hara T, Hasuo H, Tomiyasu S, Makita T, Sumikawa K. Monitored anesthesia care for a patient with malignant pheochromocytoma. Masui 1999; 48:634
141. Shiraishi M, Hnazawa K, Motoyama Y. Anesthetic management for pheochromocytoma resection using spinal cord stimulation and intravenous nicardipine: a case report. Acta Anaesthesiol Sin 1999; 37:83
142. Ulchaker JC, Goldfarb DA, Bravo EL, Novick AC. Successful outcomes in pheochromocytoma surgery in modern era. J Urol 1999; 161:764
143. Mobuis E, Nies C, Rothmund M. Surgical treatment of pheochromocytomas: laparoscopic or conventional? Surg Endosc 1999; 13:35
144. Bonjer HJ, van der Harst E, Steyeberg EW, et al. Retroperitoneal adrenalectomy: open or endoscopic? World J Surg 1998; 22:1246
145. Aoyama N, Sasagawa I, Iijima Y, Suzuki H, Kubota Y, Nakada T. Successful removal of large adrenal pheochromocytoma on the right side with liver mobilization. Int Urol Nephrol 1998; 30:377
146. Petrolo A, Borelli A, Presenti L, Valeri A, Borrelli D. New issues in surgery of adrenal pheochromocytoma. G Chir 1999; 20:57
147. Bonati L, Rubini P, Guareschi C. Diagnosis and treatment of pheochromocytoma. Minerva Chir 2000; 55:333
148. Smith CD, Weber CJ, Amerson JR. Laparoscopic adrenalectomy: new gold standard. World J Surg 1999; 23:389
149. Col V, de Cannier L, Collard E, Michel L, Donckier J. Laparoscopic adrenalectomy for pheochromocytoma: endocrinological and surgical aspects of a new therapeutic approach. Clin Endocrinol Oxf 1999; 50:121
150. Shichman SJ, Herndon CD, Sosa RE, et al. Lateral transperitoneal laparoscopic adrenalectomy. World J Urol 1999; 17:48
151. Fernandez Cruz L, Saenz A, Taura P, Benarroch G, Astudillo E, Sabater L. Retroperitoneal approach in laparascopic adrenalectomy: is it advantageous? Surg Endosc 1999; 13:86
152. Schell SR, Talamini MA, Udelsman R. Laparascopic adrenalectomy for nonmalignant disease: improved safety, morbidity, and cost-effectiveness. Surg Endosc 1999; 13:30
153. Fernandez Cruz L, Saenz A, Taura P, Sabater L, Astudillo E, Fontanals J. Helium and carbon dioxide pneumoperitoneum in patients with pheochromocytoma undergoing laparoscopic adrenalectomy. World J Surg 1998; 22:1250
154. Abboud B, Halaby G, Beyrouthy G, Chakhtoura G, Farah P. Laparoscopic adrenalectomy for pheochromocytoma. Case report and review of the literature. J Med Liban 1998; 46:291
155. Zamir G, Hazzan D, Gross DJ, et al. Laparoscopic adrenalectomy. Harefuah 2000; 138:531
156. Neumann HP, Beneder BU, Reincke M, Eggstein S, Launbenberger J, Kirste G. Adrenal sparing surgery for pheochromocytoma. Br J Surg 1999; 86:94
157. Iacconi P, Barlascini CO, Bernini G, Miccoli P. Adrenal sparing surgery for phaeochromocytoma. Br J Surg 1999, 86:1481
158. Mugiya S, Suzuki K, Saiau K, Fujita K. Unilateral laparoscopic adrenalectomy followed by contralateral retroperitoneoscopic partial adrenalectomy in a patient with multiple endocrine neoplasia type 2a syndrome. J Endourol 1999; 13:99
159. Radmayr C, Neumann H, Bartsch G, Elsner R, Janetschek G. Laparoscopic partial adrenalectomy for bilateral pheochromocytomas in a boy with von Hippel-Lindau disease. Eur Urol 2000; 38:344
160. Walther MM, Herring J, Choyke PL, Linchan WM. Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. J Urol 2000; 164:14
161. Miyauchi A, Kihara M, Maisusaka K, Nishitani A, Nishiyama Y. Successful autotransplantation of an adrenal gland using a new method of omental wrapping: report of a case. Surg Today 1999; 29:960
162. Remmel E, Oertl D, Holtzgreve W, Hosli I, Staab JJ, Harder F. Malignant pheochromocytoma in the l7th week of gestation. Chirurg 1999; 70:1053
163. Suzuki M, Mikata N, Imao S, Ishiwata S, Nagano T. Malignant pheochromocytoma with remarkable response to CVD chemotherapy: a case report. Gan To Kagaku Ryoho 2000; 27:921